A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma
一项针对转移性葡萄膜黑色素瘤患者的 Ib 期临床试验,研究了索拉司他林和比美替尼联合抑制 PKC 和 MEK 的疗效。
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.975642
Bauer, Sebastian; Larkin, James; Hodi, F Stephen; Stephen, Frank; Kapiteijn, Ellen H W; Schwartz, Gary K; Calvo, Emilano; Yerramilli-Rao, Padmaja; Piperno-Neumann, Sophie; Carvajal, Richard D